STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Common Stock

The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
	2023	2022
Shares issued and outstanding, beginning balance	60,555,661	65,968,224
Issuance of common stock from vested restricted stock units	135,074	126,522
Issuance of common stock from exercise of stock options	39,791	28,689
Issuance of common stock for the acquisition of Zenefits	—	193,221
Repurchase of common stock	(1,157,871)	(4,010,945)
Awards effectively repurchased for required employee withholding taxes	(49,701)	(46,815)
Shares issued and outstanding, ending balance	59,522,954	62,258,896

Stock Repurchases

In February 2020, our board of directors authorized a $300 million incremental increase to our ongoing stock repurchase program. In February 2022 and November 2022, our board of directors authorized a further $300 million and $200 million, respectively, incremental increase to this stock repurchase program. In February 2023, our board of directors authorized a further $300 million incremental increase to this stock repurchase program. This repurchase authorization has no expiration.